| 000 | 01724 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517163019.0 | ||
| 264 | 0 | _c20171004 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1873-2399 | ||
| 024 | 7 |
_a10.1016/j.exphem.2017.06.349 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSena, Isadora F G | |
| 245 | 0 | 0 |
_aIdentity of Gli1 _h[electronic resource] |
| 260 |
_bExperimental hematology _c10 2017 |
||
| 300 |
_a12-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aBone Marrow Cells _xdrug effects |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aPlatelet Factor 4 _xgenetics |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aZinc Finger Protein GLI1 _xantagonists & inhibitors |
| 700 | 1 | _aPrazeres, Pedro H D M | |
| 700 | 1 | _aSantos, Gabryella S P | |
| 700 | 1 | _aBorges, Isabella T | |
| 700 | 1 | _aAzevedo, Patrick O | |
| 700 | 1 | _aAndreotti, Julia P | |
| 700 | 1 | _aAlmeida, Viviani M | |
| 700 | 1 | _aPaiva, Ana E | |
| 700 | 1 | _aGuerra, Daniel A P | |
| 700 | 1 | _aLousado, Luiza | |
| 700 | 1 | _aSouto, Luanny | |
| 700 | 1 | _aMintz, Akiva | |
| 700 | 1 | _aBirbrair, Alexander | |
| 773 | 0 |
_tExperimental hematology _gvol. 54 _gp. 12-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exphem.2017.06.349 _zAvailable from publisher's website |
| 999 |
_c27350624 _d27350624 |
||